On the other hand, studies conducted by Perrotta et al. and Flikweert et al. did not involve patients with liver cirrhosis, and they observed low serum adiponectin levels in severe COVID-19 patients compared to healthy controls. This evidence concerns the gene ADIPOQ and cirrhosis of liver.